During the past decade, ICO Girona conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 13 clinical trials were completed, i.e. on average, 25.5% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 13 clinical trials were completed. i.e. 40.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ICO Girona" #1 sponsor was "Fundación GECP" with 8 trials, followed by "PETHEMA Foundation" with 6 trials sponsored, "Spanish Breast Cancer Research Group" with 5 trials sponsored, "Grupo Español de Investigación en Cáncer de Ovario" with 4 trials sponsored and "Janssen Research & Development, LLC" with 4 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ICO Girona" #1 collaborator was "Hoffmann-La Roche" with 6 trials as a collaborator, "Apices Soluciones S.L." with 3 trials as a collaborator, "GlaxoSmithKline" with 3 trials as a collaborator, "AGO Study Group" with 2 trials as a collaborator and "ARCAGY/ GINECO GROUP" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "ICO Girona" are "Breast Cancer" (6 trials), "Multiple Myeloma" (4 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "Oral Mucositis" (3 trials) and "Early Breast Cancer" (2 trials). Many other conditions were trialed in "ICO Girona" in a lesser frequency.

Most popular intervention types in "ICO Girona" are "Drug" (55 trials), "Other" (7 trials), "Radiation" (4 trials), "Biological" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Carboplatin" (9 trials), "Atezolizumab" (7 trials), "Bevacizumab" (6 trials) and "Paclitaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "ICO Girona" are 42 trials for "All" genders, 16 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "ICO Girona". undefined are not yet recruiting, 16 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in ICO Girona, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in ICO Girona, 5 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".